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Abstract 
The PIXE method has been used to compare a reference group (N=100) and 
eight groups of patients suffering from hematological malignancies 
(Hodgkin's disease, lymphosarcoma, chronic lymphocytic leukemia, acute 
lymphocytic leukemia, acute granulocytic leukemia, chronic granulocytic 
leukemia, myeloproliferative disorders and myeloma) (N=140). 
The serum Cl, K, Ca, Fe, Cu, Zn, Se and Br contents have been measured. 
Significative differences were noted in several groups. A statistical 
analysis has been performed to correlate these trace element values with 
several clinical and biological parameters such as blood cells counting, 
clinical stage, histology, inflanrnatory tests, ... 
Introduction 
Trace elements metabolism has already been extensively studied in various 
medical fields (1, 2). In hematology, many authors have reported on serum 
copper increase in Hodgkin's disease and lymphosarcoma and return to 
normal values when complete remission is achieved (3, 4, 5, 6). Much less 
has been described about other trace elements, especially about bromine 
who se role in human metabolism remains obscure. 
We report here on our experience with serum trace elements dosage and 
confirm our previous conrnunication (7) on abnormal values in several 
hemoproliferative diseases. 
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Patients and methods 
The PIXE method has been used to measure the serum content of chlorine 
(Cl), potassium (K), calcium (Ca), iron (Fe), copper (Cu), zinc (Zn), 
selenium (Se) and bromine (Br), in normal subjects and in patients 
suffering from hemoproliferative diseases. 
1) Normal subjects. This group was composed of 100 healthy subjects 
taking no drug. Although this group was rather younger than our patient 
group, no significant difference with age was noted in trace Element 
values. We found a statistically significant difference between sexes 
in calcium (103 in male versus 100 ug/ml in female, p = 0.03), copper 
(1.05 in male versus 1.17 ug/ml in female, p = 0.02), zinc (1.14 in 
male versus 1.01 ug/ml in female, p < 0.001). 
2) Patients. 319 samples were taken from 150 patients, many of them being 
studied on several occasions, bath in active disease and in remission. 
They are divided up as follows : myeloma (MY: 20), Hodgkin's disease 
(HO: 12), lymphosarcoma (lS : 28), chronic lymphocytic leukemia (Cll: 
26), acute lymphocytic leukemia (All : 6), acute myelocytic leukemia 
(Ai'll: 26), chronic myelocytic leukemia ((Ml: 11) and myeloprolifera-
tive disorders (MPS : 21). 
We also studied serum trace elements values according to clinical 
status and sorne biological parameters usually regarded as representative 
of disease activity. So blood cell counting, erythrocyte, sedimentation 
rate, fibrinogen, serum lactate deshydrogenase (LDH) and serum proteins 
were recorded on the same day as the trace Elements. 
Thirteen patients presenting with newly diagnosed or relapsing AMl and 
undergoing intensive induction chemotherapy, have been serially 
followed for up to three months. The chemotherapy regimen generally 
consisted in a seven-day course associating high doses of daunomycine, 
vincristine and cytosine-arabinoside. Samples were taken before 
treatment and then about twi ce a Itleek. 
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Table 1 - Serum copper, zinc and bromine (ug/ml) in controls and different 
patieht groups, P-value for Student t-test is given when 
significant. ïABLE 1. 
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different patient groups, with range demonstrated. 
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Results 
The mean val~es for copper, zinc and bromine in normal subjects and in 
patients are listed in Table 1. P-values for student t-test between 
controls and patients are mentioned when significant. Ranges are shawn 
in Figure 1, but sorne very high values for bromine are outside this 
pi cture. 
Copper was always increased when compared with controls, and this reached 
statistical significance in all groups but ALL which was too small. Zinc 
was significantly reduced in all patient groups, though the absolute 
difference wasntt important in every groups. 
Bromine displayed sorne less systematic pattern. Tt was significantly 
decreased in AI-IL, CLL and myeloma, but in A'IL this feature is dependent 
upon treatment (see below); it was slightly reduced in lymphosarcoma, (ML 
and ALL, and slightly enhanced in HD and MPS, but in these groups most 
values \vere in fa ct very 10w and the mean artificially normalised by very 
high values. 
Selenium showed no difference neither in absolute value nor in range. 
Chlorine and calcium remained almost constant tram group ta group. Potas-
sium was often increased, reflecting extensive cellular turn-over. Iron 
was sometimes reduced, mostly in CLL and LS groups vlhe}~e copper reached 
the highest leveis. 
Because of the small size of sorne groups, one must be careful in inter-
preting apparent correlations betltleen trace Elements and biological para-
meters. SA we shall report only on the most important ones. t~ithin the 
patient group as a whole, copper is correlated with white blood cell 
counts, inflammatory tests, serum LDH and potassium; zinc disclosed a 
weak correlation with calcium, iron and selenium, and bramine It,:ith potas-
sium; potassium was related ta whale blood cell counts 1 serum proteins 
and chiorine; calcium increased with serum proteins, chlorine, potassium 
and selenium. 
In CLL, capper was correlated with l,SC counis (R=O.71, P < 0.001), serum 
LDH (R=0.796, P < 0.001), ESR (R=0.504, P < 0.05) but not with fibrinogen; 
on the opposite, selenium was inversely correlated with WBC counts 
(p '" 0,01). In lymphosarcoma, copper shOl'/ed significant correlation with 
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Fig. 2 - Capper and bromine Evolution in patients undergoing chemo-
therapy for ANL? Mean values + Cf are given with comparison 
with A~L in complete remission (CR) and normal controls (N). 
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Fig. 3 - A typical pattern of bromine! capper and zinc Evolution during 
chemotherapy in a 20 year old >!oman with l'ML. 
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ESR and fibr;nogen! and inverse relationship with hemoglobin. 
The A~L patients undergoing intensive chemotherapy bore a characteristic 
evolution (Figure 2). The mean values before treatment were 5.79 + 2.07 
ug/ml for bromine and 1.57 ~ 0.37 ug/ml for copper. Bromine dropped 
dramatically to 2. 74 ~ 1.45 on day 14 and 2.10 ~ 0.48 ug/ml on day 28; the 
level remained low for several weeks and then progressively reached normal 
pre-treatment values. Copper displayed a less constant pattern but usually 
eut down during chemotherapy and thereafter reaugmented to significantly a 
higher level (1.79 ~ 0.43 ug/ml on day 21). A few weeks later, while in 
complete remission, dosage reduced to 1.21 ~ 0.28 ug/ml, thus only slight-
ly more than in controls. A typical pattern is presented in Figure 3 with 
a 20 yeal" old woman undergoing three chemotherapy courses for refractory 
PML. 
Cane lus ions 
1) Zinc ~s systematically reduced in hemoproliferative diseases. ïhis has 
not 2\·;2.Y5 ~€en confir:71ed (8) and doesn't seem ta be related ta nutri-
tion s-:atus~ treat::lent or other biological abnomalies. It may be due 
ta t~ss:.;:ar cat2!bolism in cancer patients (1 g 2). 
2) Copper is usually enhanced in our patients but considerable overlap 
with :1:Jrma: values prevents us fram its excessive ciinical use. None-
the'I€SS~ we found a significant correlation between copper j and 
infl,a!7i~atory tests in LS (3-6) ~ and WBC chiefly in CLL. 
3) Brom~r;e remair,$ misunderstood in human metaboiism. Although we observed 
a genera"1 tendency tO\.<Jards decreased values in patients ~ very high 
values were noted~ that viere not reiated ta any l3€culiar disease 
status nor ta drug intake. The fan noticed in AML chemotherapy \I/as 
independent of digestive Tolerance ta disease and treatment. This l,<Jas 
supported by the absence of such a phenomenon in patients undergoing 
a slimming fast (unpublished data). This drop seemed to be due to 
chemotherapy itself. 
4) Selenium is much the same in our patient groups as in controls. But 
measured concentration is very low and errors may be relevant. 
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